About The Alfred Foundation
The Alfred Foundation creates and nurtures philanthropic partnerships between the community and The Alfred.
Through The Alfred Foundation, individuals, community groups and organisations can contribute to The Alfred's role in saving lives, improving the health of our community, and advancing medical research.
Each year, we receive remarkable support from the community, Trusts, foundations, estates, individuals, corporate partners, and other local and national organisations.
This generosity has enabled us to work together to drive innovation and change at the hospital across a range of projects, such as redeveloping the Emergency & Trauma Centre and building The Alfred Centre.
Life Support Committee
Life Support was formed in 2003 to help The Alfred minimise the devastating impact of trauma. Born from the tragedy of the 2002 Bali Bombings, Life Support has generated over $1 million for the purchase of life-saving equipment.
Women @ The Alfred
Since 2001 the W@TA have donated in excess of $4 million to support the early detection and treatment of those impacted by prostate cancer, including helping to establish a dedicated Prostate Cancer Clinic at The Alfred Centre.
Our Board
Responsiveness along with sound and transparent decisions are key principles in The Alfred Foundation's governance process.
Privacy Statement
The Alfred Foundation respects, and is committed to protecting your privacy.
You might also be interested in...
Latest news
Include a Charity Week: Nilanthi’s story
This week is Include a Charity Week, an Australian campaign designed to encourage more people to think about remembering their favourite charities in their Wills.
Advancing discovery through biobanks
This week The Alfred Brain Tumour Bio-databank (ABTB) discovered a new hope in the treatment for brain cancer. The ABTB is one of three biobanks at The Alfred advancing research into new treatments.
Ned’s enduring legacy to fight leukaemia
At just 21, Ned Parnham had his whole life ahead of him, but in November 2018 the Melbourne University Environmental Science student was diagnosed with a rare form of Acute Myeloid Leukaemia (AML)